praziquantel has been researched along with Mast Cell Activation Disease in 2 studies
azinox: Russian drug
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hrckova, G | 1 |
Velebný, S | 1 |
Daxnerová, Z | 1 |
Solár, P | 1 |
Starke, WA | 1 |
Oaks, JA | 1 |
2 other studies available for praziquantel and Mast Cell Activation Disease
Article | Year |
---|---|
Praziquantel and liposomized glucan-treatment modulated liver fibrogenesis and mastocytosis in mice infected with Mesocestoides vogae (M. corti, Cestoda) tetrathyridia.
Topics: Animals; Anthelmintics; beta-Glucans; Bromodeoxyuridine; Cestode Infections; Collagen; Drug Therapy, | 2006 |
Hymenolepis diminuta: praziquantel removal of adult tapeworms is followed by apoptotic down-regulation of mucosal mastocytosis.
Topics: Animals; Antiplatyhelmintic Agents; Apoptosis; Down-Regulation; Hymenolepiasis; Hymenolepis; Ileum; | 1999 |